AU2002211602A1 - Polymer controlled delivery of a therapeutic agent - Google Patents
Polymer controlled delivery of a therapeutic agentInfo
- Publication number
- AU2002211602A1 AU2002211602A1 AU2002211602A AU1160202A AU2002211602A1 AU 2002211602 A1 AU2002211602 A1 AU 2002211602A1 AU 2002211602 A AU2002211602 A AU 2002211602A AU 1160202 A AU1160202 A AU 1160202A AU 2002211602 A1 AU2002211602 A1 AU 2002211602A1
- Authority
- AU
- Australia
- Prior art keywords
- therapeutic agent
- controlled delivery
- polymer controlled
- polymer
- delivery
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US23938500P | 2000-10-11 | 2000-10-11 | |
US23949800P | 2000-10-11 | 2000-10-11 | |
US60/239,498 | 2000-10-11 | ||
US60/239,385 | 2000-10-11 | ||
PCT/US2001/031688 WO2002030399A2 (en) | 2000-10-11 | 2001-10-11 | Polymer controlled delivery of a therapeutic agent |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002211602A1 true AU2002211602A1 (en) | 2002-04-22 |
Family
ID=26932523
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002211602A Abandoned AU2002211602A1 (en) | 2000-10-11 | 2001-10-11 | Polymer controlled delivery of a therapeutic agent |
Country Status (3)
Country | Link |
---|---|
US (1) | US20030008015A1 (en) |
AU (1) | AU2002211602A1 (en) |
WO (1) | WO2002030399A2 (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AUPR098300A0 (en) | 2000-10-25 | 2000-11-16 | Sirtex Medical Limited | Polymer based radionuclide containing microspheres |
US20050043585A1 (en) * | 2003-01-03 | 2005-02-24 | Arindam Datta | Reticulated elastomeric matrices, their manufacture and use in implantable devices |
JP2007521843A (en) | 2003-05-15 | 2007-08-09 | バイオメリクス コーポレーション | Reticulated elastomeric matrix, its manufacture and use in implantable devices |
US7763077B2 (en) | 2003-12-24 | 2010-07-27 | Biomerix Corporation | Repair of spinal annular defects and annulo-nucleoplasty regeneration |
US20070190108A1 (en) * | 2004-05-17 | 2007-08-16 | Arindam Datta | High performance reticulated elastomeric matrix preparation, properties, reinforcement, and use in surgical devices, tissue augmentation and/or tissue repair |
US20060116714A1 (en) * | 2004-11-26 | 2006-06-01 | Ivan Sepetka | Coupling and release devices and methods for their assembly and use |
WO2008074027A1 (en) * | 2006-12-13 | 2008-06-19 | Biomerix Corporation | Aneurysm occlusion devices |
CN101790380B (en) | 2007-02-07 | 2013-07-10 | 加利福尼亚大学董事会 | Conjugates of synthetic TLR agonists and uses therefor |
JP2011511073A (en) * | 2008-02-07 | 2011-04-07 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | Treatment of bladder disease with TLR7 activator |
RU2659936C2 (en) | 2012-03-06 | 2018-07-04 | Зэ Борд оф Трастиз оф зэ Юниверсити оф Иллинойс | Procaspase 3 activation by combination therapy |
US20160346221A1 (en) | 2015-06-01 | 2016-12-01 | Autotelic Llc | Phospholipid-coated therapeutic agent nanoparticles and related methods |
US11697851B2 (en) | 2016-05-24 | 2023-07-11 | The Regents Of The University Of California | Early ovarian cancer detection diagnostic test based on mRNA isoforms |
CA3082575A1 (en) | 2017-11-17 | 2019-05-23 | The Board Of Trustees Of The University Of Illinois | Cancer therapy by degrading dual mek signaling |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2755136B1 (en) * | 1996-10-25 | 1999-01-22 | Virsol | PROCESS FOR THE PREPARATION OF METHYLIDENE MALONATE NANOPARTICLES, NANOPARTICLES CONTAINING ONE OR MORE BIOLOGICALLY ACTIVE MOLECULES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
FR2778100B1 (en) * | 1998-04-29 | 2001-05-04 | Virsol | NOVEL POLY (METHYLIDENE MALONATE) MICROSPHERES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
-
2001
- 2001-10-11 AU AU2002211602A patent/AU2002211602A1/en not_active Abandoned
- 2001-10-11 WO PCT/US2001/031688 patent/WO2002030399A2/en active Application Filing
- 2001-10-11 US US09/975,565 patent/US20030008015A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2002030399A2 (en) | 2002-04-18 |
WO2002030399A3 (en) | 2003-01-03 |
US20030008015A1 (en) | 2003-01-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001273341A1 (en) | An implantable or insertable therapeutic agent delivery device | |
AU2002322719A1 (en) | Delivery of therapeutic capable agents | |
AU2623201A (en) | Controlled delivery of therapeutic agents by insertable medical devices | |
AU2002232618A1 (en) | Tissue attachable drug delivery catheters/methods of use | |
AU2001279064A1 (en) | Therapeutic azo-compounds for drug delivery | |
AU2002213357A1 (en) | Variant igg3 rituxan r and therapeutic use thereof | |
AU2001238386A1 (en) | Medication delivery devices | |
AU2001235009A1 (en) | Drug delivery apparatus | |
AU2001264887A1 (en) | Drug delivery device | |
AU2002218250A1 (en) | Medicament dispenser | |
AU2006601A (en) | Medicament dispenser | |
AU2509901A (en) | Medicament dispenser | |
AU2002246925A1 (en) | Therapeutic delivery balloon | |
AU2003251563A1 (en) | Implatable or insertable medical devices for controlled delivery of a therapeutic agent | |
AU2001258095A1 (en) | Drug delivery systems for photodynamic therapy | |
AU2002246515A1 (en) | Medicated tattoos | |
AU2123200A (en) | Drug delivery device | |
AU2002242883A1 (en) | Medicament dispenser | |
AU2002251238A1 (en) | Medicament dispenser | |
AU2002358805A1 (en) | Medicament dispenser | |
AU4947100A (en) | Drug delivery device | |
AU2002223562A1 (en) | Medicament dispenser | |
AU1514401A (en) | Medicament dispenser | |
AU2001277171A1 (en) | Catheter for target specific drug delivery | |
AU2002211602A1 (en) | Polymer controlled delivery of a therapeutic agent |